73 related articles for article (PubMed ID: 8549326)
1. Comparative in vitro activity of BAY Y 3118 against selected species.
Verbist L; Verhaegen J
Drugs; 1995; 49 Suppl 2():264-5. PubMed ID: 8549326
[No Abstract] [Full Text] [Related]
2. Comparative in vitro activity of BAY Y 3118 with other fluoroquinolones.
Molinari G; Schito GC
Drugs; 1995; 49 Suppl 2():222-5. PubMed ID: 8549310
[No Abstract] [Full Text] [Related]
3. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.
Azadian BS; Talboys CA; Roberts AP
J Chemother; 1989 Jul; 1(4 Suppl):176-7. PubMed ID: 16312357
[No Abstract] [Full Text] [Related]
4. Comparative in vitro activities of new quinolones against coryneform bacteria.
Martínez-Martínez L; Suárez AI; Ortega MC; Perea EJ
Antimicrob Agents Chemother; 1994 Jun; 38(6):1439-41. PubMed ID: 8092851
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility to ciprofloxacin of bacterial strains isolated from chronic otitis media and chronic sinusitis.
Gaillot O; Berche P
Drugs; 1995; 49 Suppl 2():200-2. PubMed ID: 8549303
[No Abstract] [Full Text] [Related]
6. In vitro activity of sparfloxacin compared with ciprofloxacin and ofloxacin against respiratory tract pathogens.
Malmborg AS; Ahlén S
Chemotherapy; 1993; 39(1):32-5. PubMed ID: 8383030
[TBL] [Abstract][Full Text] [Related]
7. A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers.
Beskid G; Prosser BL
Am J Med; 1993 Mar; 94(3A):2S-8S. PubMed ID: 8383919
[TBL] [Abstract][Full Text] [Related]
8. The new 4-quinolones DU-6859a and DV-7751a show enhanced activity against Streptococcus pneumoniae.
Morrissey I; Smith JT
Drugs; 1995; 49 Suppl 2():228-9. PubMed ID: 8549312
[No Abstract] [Full Text] [Related]
9. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].
Derevianko II; Lopatkin NA; Khodyreva LA; Kondrat'eva EM
Urol Nefrol (Mosk); 1998; (5):14-8. PubMed ID: 9820038
[No Abstract] [Full Text] [Related]
10. In vitro activity of MF 5137, a new potent 6-aminoquinolone.
Wise R; Pagella PG; Cecchetti V; Fravolini A; Tabarrini O
Drugs; 1995; 49 Suppl 2():272-3. PubMed ID: 8549329
[No Abstract] [Full Text] [Related]
11. [Comparative activities in vitro of 4 quinolones (nalidixic acid, pefloxacin, norfloxacin, ofloxacin) on 13 bacterial species].
Rahal K
Arch Inst Pasteur Alger; 1992; 58():41-84. PubMed ID: 1309146
[TBL] [Abstract][Full Text] [Related]
12. In vitro antibacterial activity of FA103, a new quinolone derivative of C-7 position with 7-perhydrodiazepinone.
Imamori K; Asaoka T; Matsumoto M; Maebashi K; Matsuda H; Tahara Y
Jpn J Antibiot; 1995 Dec; 48(12):1891-8. PubMed ID: 8587163
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.
Mirelis B; Navarro F; Miró E; Coll R; Xicota MA; Prats G
Drugs Exp Clin Res; 1995; 21(4):129-38. PubMed ID: 8529525
[TBL] [Abstract][Full Text] [Related]
14. In-vitro activity of OPC-17116 against more than 6000 consecutive clinical isolates: a multicentre international study.
Marco F; Jones RN; Hoban DJ; Pignatari AC; Yamane N; Frei R
J Antimicrob Chemother; 1994 Mar; 33(3):647-54. PubMed ID: 8040130
[No Abstract] [Full Text] [Related]
15. The antimicrobial activity of sparfloxacin, a new quinolone.
Paradelis AG; Delidou K; Grigoriadou A; Salpigides G; Pangalis A
Drugs; 1995; 49 Suppl 2():238-9. PubMed ID: 8549316
[No Abstract] [Full Text] [Related]
16. Activity of sparfloxacin against Mycobacterium leprae measured by the proportional bactericidal test.
McDermott-Lancaster RD; Banerjee DK
Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):605-8. PubMed ID: 8151193
[TBL] [Abstract][Full Text] [Related]
17. The in-vitro activity of a new highly active quinolone, DU-6859a.
Jolley A; Andrews JM; Brenwald N; Wise R
J Antimicrob Chemother; 1993 Nov; 32(5):757-63. PubMed ID: 8125840
[No Abstract] [Full Text] [Related]
18. Activity of new 4-quinolones in combination with erythromycin or tetracycline against S. pneumoniae.
Morrissey I; Smith JT
Drugs; 1995; 49 Suppl 2():226-7. PubMed ID: 8549311
[No Abstract] [Full Text] [Related]
19. In vitro susceptibility of mycoplasmas to a new quinolone, BAY Y 3118.
Renaudin H; Bébéar C
Drugs; 1995; 49 Suppl 2():243-5. PubMed ID: 8549318
[No Abstract] [Full Text] [Related]
20. In vitro evaluation of lomefloxacin (NY-198 or SC-47111), a new difluoro-quinolone.
Jones RN
J Chemother; 1989 Jul; 1(4 Suppl):165-7. PubMed ID: 16312353
[No Abstract] [Full Text] [Related]
[Next] [New Search]
